TY  - GEN
AU  - Fuster,Daniel
AU  - Huertas,Jaime A
AU  - Gómez,Guadalupe
AU  - Solà,Ricard
AU  - González García,Juan
AU  - Vilaró,Josep
AU  - Pedrol,Enric
AU  - Force,Lluís
AU  - Tor,Jordi
AU  - Sirera,Guillem
AU  - Videla,Sebastiá
AU  - Planas,Ramon
AU  - Clotet,Bonaventura
AU  - Tural,Cristina
TI  - Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy
SN  - 1359-6535
PY  - 2006///0821
KW  - Adult
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - Hepatitis C
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Risk Factors
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
ER  -